| Product Code: ETC8978444 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Romania Pharmacovigilance Market is witnessing steady growth due to increasing regulatory requirements and a growing focus on patient safety. The market is driven by the rising number of adverse drug reactions reported, leading to a higher demand for pharmacovigilance services. Pharmaceutical companies in Romania are investing in pharmacovigilance activities to comply with regulations and ensure drug safety. Additionally, the implementation of stringent guidelines by regulatory authorities is further propelling market growth. Outsourcing pharmacovigilance services to specialized vendors is also a common practice among pharmaceutical companies in Romania to streamline operations and reduce costs. Overall, the Romania Pharmacovigilance Market is expected to continue expanding as the healthcare industry emphasizes the importance of drug safety and regulatory compliance.
The Romania Pharmacovigilance Market is experiencing significant growth due to the increasing focus on drug safety regulations and the rising number of adverse drug reactions reported. One key trend is the adoption of advanced technologies such as artificial intelligence and big data analytics to enhance pharmacovigilance processes and improve patient safety. Opportunities in the market include the expansion of pharmacovigilance services by outsourcing companies, collaborations between pharmaceutical companies and regulatory authorities to streamline reporting procedures, and the growing demand for pharmacovigilance professionals with specialized skills. Additionally, the implementation of the EU`s new pharmacovigilance legislation and the increasing number of clinical trials being conducted in Romania are driving the demand for pharmacovigilance services in the country.
In the Romania Pharmacovigilance Market, some of the key challenges faced include limited resources and infrastructure for effective monitoring and reporting of adverse drug reactions, lack of awareness among healthcare professionals about the importance of pharmacovigilance, and regulatory complexities that may hinder the timely and accurate submission of safety data. Additionally, there is a shortage of skilled personnel trained in pharmacovigilance activities, leading to potential gaps in monitoring and evaluating drug safety. Furthermore, the need to align with European Union regulations and standards adds another layer of complexity for pharmacovigilance activities in Romania. Overcoming these challenges will require investment in training programs, improved communication and collaboration among stakeholders, and streamlined processes to ensure efficient pharmacovigilance practices in the country.
The Romania Pharmacovigilance Market is primarily driven by increasing regulatory requirements and the growing emphasis on drug safety monitoring to ensure patient well-being. The rise in adverse drug reactions and the need for effective risk management strategies have propelled the demand for pharmacovigilance services in the country. Additionally, the expanding pharmaceutical industry in Romania, coupled with the growing number of clinical trials and drug approvals, is fueling the demand for pharmacovigilance activities to assess and monitor drug safety profiles. The adoption of advanced technologies such as artificial intelligence and big data analytics for pharmacovigilance processes is also contributing to market growth by enhancing efficiency and accuracy in adverse event detection and reporting.
In Romania, the Pharmacovigilance Market is governed by various regulations and policies aimed at ensuring the safety and efficacy of pharmaceutical products. The National Agency for Medicines and Medical Devices (NAMMD) is responsible for overseeing pharmacovigilance activities in the country, in line with European Union directives. The Romanian pharmacovigilance system complies with the requirements set out in Directive 2001/83/EC and Regulation (EC) No 726/2004, which mandate the reporting and monitoring of adverse drug reactions. Pharmaceutical companies are required to submit periodic safety update reports to the NAMMD, and healthcare professionals are encouraged to report any suspected adverse reactions. Additionally, Romania has implemented the Good Pharmacovigilance Practice (GVP) guidelines to ensure high standards of pharmacovigilance activities in the country.
The future outlook for the Romania Pharmacovigilance Market appears promising, driven by factors such as increasing focus on patient safety, stringent regulatory requirements, and the rising number of adverse drug reactions. The market is expected to witness steady growth as pharmaceutical companies and regulatory authorities continue to emphasize the importance of pharmacovigilance in ensuring the safety and efficacy of drugs. Additionally, advancements in technology, such as artificial intelligence and big data analytics, are likely to enhance pharmacovigilance practices and streamline drug safety monitoring processes in Romania. With the growing demand for pharmacovigilance services and the increasing complexity of the healthcare landscape, the Romania Pharmacovigilance Market is poised for expansion in the coming years.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Romania Pharmacovigilance Market Overview |
3.1 Romania Country Macro Economic Indicators |
3.2 Romania Pharmacovigilance Market Revenues & Volume, 2021 & 2031F |
3.3 Romania Pharmacovigilance Market - Industry Life Cycle |
3.4 Romania Pharmacovigilance Market - Porter's Five Forces |
3.5 Romania Pharmacovigilance Market Revenues & Volume Share, By Clinical Trial Phase, 2021 & 2031F |
3.6 Romania Pharmacovigilance Market Revenues & Volume Share, By Service Provider, 2021 & 2031F |
3.7 Romania Pharmacovigilance Market Revenues & Volume Share, By Type of Reporting, 2021 & 2031F |
3.8 Romania Pharmacovigilance Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Romania Pharmacovigilance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing focus on patient safety and regulatory compliance |
4.2.2 Growing prevalence of adverse drug reactions and drug-related issues |
4.2.3 Technological advancements in pharmacovigilance systems and tools |
4.3 Market Restraints |
4.3.1 Lack of skilled professionals in pharmacovigilance |
4.3.2 Stringent regulatory requirements and complex reporting procedures |
5 Romania Pharmacovigilance Market Trends |
6 Romania Pharmacovigilance Market, By Types |
6.1 Romania Pharmacovigilance Market, By Clinical Trial Phase |
6.1.1 Overview and Analysis |
6.1.2 Romania Pharmacovigilance Market Revenues & Volume, By Clinical Trial Phase, 2021- 2031F |
6.1.3 Romania Pharmacovigilance Market Revenues & Volume, By Preclinical, 2021- 2031F |
6.1.4 Romania Pharmacovigilance Market Revenues & Volume, By Phase I, 2021- 2031F |
6.1.5 Romania Pharmacovigilance Market Revenues & Volume, By Phase II, 2021- 2031F |
6.1.6 Romania Pharmacovigilance Market Revenues & Volume, By Phase III, 2021- 2031F |
6.1.7 Romania Pharmacovigilance Market Revenues & Volume, By Phase IV, 2021- 2031F |
6.2 Romania Pharmacovigilance Market, By Service Provider |
6.2.1 Overview and Analysis |
6.2.2 Romania Pharmacovigilance Market Revenues & Volume, By In-house, 2021- 2031F |
6.2.3 Romania Pharmacovigilance Market Revenues & Volume, By Contract Outsourcing, 2021- 2031F |
6.3 Romania Pharmacovigilance Market, By Type of Reporting |
6.3.1 Overview and Analysis |
6.3.2 Romania Pharmacovigilance Market Revenues & Volume, By Spontaneous Reporting, 2021- 2031F |
6.3.3 Romania Pharmacovigilance Market Revenues & Volume, By Intensified ADR Reporting, 2021- 2031F |
6.3.4 Romania Pharmacovigilance Market Revenues & Volume, By Targeted Spontaneous Reporting, 2021- 2031F |
6.3.5 Romania Pharmacovigilance Market Revenues & Volume, By Cohort Event Monitoring, 2021- 2031F |
6.3.6 Romania Pharmacovigilance Market Revenues & Volume, By EHR Mining, 2021- 2031F |
6.4 Romania Pharmacovigilance Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Romania Pharmacovigilance Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Romania Pharmacovigilance Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F |
6.4.4 Romania Pharmacovigilance Market Revenues & Volume, By Other End Users, 2021- 2031F |
7 Romania Pharmacovigilance Market Import-Export Trade Statistics |
7.1 Romania Pharmacovigilance Market Export to Major Countries |
7.2 Romania Pharmacovigilance Market Imports from Major Countries |
8 Romania Pharmacovigilance Market Key Performance Indicators |
8.1 Number of reported adverse drug reactions |
8.2 Percentage increase in pharmacovigilance training programs attendance |
8.3 Adoption rate of pharmacovigilance software solutions |
8.4 Compliance rate with pharmacovigilance regulations |
8.5 Time taken to process and analyze pharmacovigilance data |
9 Romania Pharmacovigilance Market - Opportunity Assessment |
9.1 Romania Pharmacovigilance Market Opportunity Assessment, By Clinical Trial Phase, 2021 & 2031F |
9.2 Romania Pharmacovigilance Market Opportunity Assessment, By Service Provider, 2021 & 2031F |
9.3 Romania Pharmacovigilance Market Opportunity Assessment, By Type of Reporting, 2021 & 2031F |
9.4 Romania Pharmacovigilance Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Romania Pharmacovigilance Market - Competitive Landscape |
10.1 Romania Pharmacovigilance Market Revenue Share, By Companies, 2024 |
10.2 Romania Pharmacovigilance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |